9th Scientific Merit Awards
Dr Terusha Chetty is a clinician and epidemiologist dedicated to the health of vulnerable women and children living with and affected by HIV.
With over 15 years of maternal and child health research experience in South Africa, her PhD cohort study of over 26,000 pregnancies explored HIV incidence during pregnancy and early postpartum and virological control and birth outcomes in HIV-infected women on antiretroviral therapy in rural KwaZulu-Natal. Her expertise and focal research areas are also in health system processes which affect maternal and perinatal mortality and the implementation of interventions to reduce HIV transmission in pregnant and postpartum women.
Dr Chetty is a National Research Foundation Y-rated scientist and was one of two South African scientists chosen to attend the 13th HOPE Conference led by Nobel laureates and hosted by the Japanese society for the promotion of science. She also received an Epidemiology training fellowship from the Columbia University-South African Fogarty AIDS International Training and Research programme and was funded through the SAMRC Clinician Researcher Programme to complete her PHD from 2013-2017.
Dr Chetty holds a diploma in child health, a specialist degree in public health medicine from the University of Kwa-Zulu Natal, a Master’s in Epidemiology from Columbia University and a PhD Public Health from the University of Kwa-Zulu Natal.
As part of her commitment to transformation, Dr Chetty is also affiliated with the School of Nursing and Public Health at the University of KwaZulu-Natal and believes in empowering local scientists to build sustainable health research capacity in South Africa. Now as a Specialist Clinician Scientist at the HIV and Other Infectious Disease Research Unit, one of her four studies she is leading focuses on the safety and effectiveness of the Ad26.SARS. COV2 vaccine in pregnant and breastfeeding women in South Africa.
Professor Tivani Mashamba-Thompson is a professor of diagnostics research and Deputy Dean of Research and Postgraduate studies at the University of Pretoria. co-Director of Marti TB Diagnostics Pty (Ltd) and Lead PI of the REASSURED-d@UP research group at University of Pretoria.
Her expertise and focal research areas are in: The implementation of point-of-care diagnostics for resource limited settings and underserved populations.
In 2014 she received the Golden key outstanding scholarly award, obtained her PhD in 2017 and first NRF rating in 2018. In 2019 the NRF & Japan Society for promotion of science HOPE fellowship award and in the same year she won the University of Kwa-Zulu Natal (UKZN) most published female researcher and among the top 5 most cited researchers at UKZN. She was also among the 2020 Mail and Guardian Newspaper list of most powerful women in South Africa.
Professor Mashamba-Thompson holds an Honors Degree in Applied Biomedical Science from University of Surrey, postgraduate diploma in Biomedical Science from the University of Greenwich, a Master’s in Pharmaceutical Chemistry, a Clinical Research Graduate Certificate from Harvard University and a PhD in Public Health from the University of Kwa-Zulu Natal. Completed her postdoc training with the CIHR Canadian HIV Trials Network.
Prof Mashamba-Thompson co-led a South African Medical Research Council covid-19 response study, which was aimed at evaluating new SARS CoV-2 point-of-care diagnostics.
Professor Lusilda Schutte is an Associate Professor at the Africa Unit for Transdisciplinary Health Research of the North-West University and a registered and practicing Clinical Psychologist.
Her research interests include public mental health and psychiatric epidemiology, where she considers mental health on the full spectrum from ill-being to well-being and has a specific interest in the social determinants of mental health.
She received a Y1 NRF rating in 2022 and was the recipient of the Emerging Scientist Award of the Psychological Society of South Africa’s Division for Research and Methodology in 2019. She held an NRF Thuthuka grant from 2020 to 2022 and forms part of the South African Medical Research Council’s Early Investigators Programme since 2022. Prof Schutte was the lead editor of a 2022 Springer volume titled “Embracing well-being in diverse African contexts: Research perspectives.”She was invited to convene an Invited Symposium at the International Congress of Psychology in Prague in 2021 and was invited to present in the “Showcasing Early Career Researchers Invited Symposium” at the 6th World Congress of Positive Psychology in Melbourne, Australia, in 2019.
Building on a bachelor’s degree with Mathematics, Statistics, and Psychology as majors, Prof Schutte holds a Doctoral in Psychology degree from the North-West University and Master’s degrees in both Clinical Psychology and Statistics.
Prof Schutte’s role with the South African Medical Research Council began when she was awarded a research grant in their Early Investigators Programme for 2022-2026. The project is entitled: “Trajectories, determinants, and correlates of mental health in the PURE-SA cohort”.
Dr Wynand Johan Goosen is a International Wellcome Trust Researcher with Stellenbosch University, Aberdeen University (Scotland) and Western University (Canada), he is the Vice Chairman of the Wildlife Disease Association for Africa and Middle East and National Geographic Explorer.
Dr Goosen is fascinated and devoted towards understanding and improving the surveillance of zoonotic tuberculosis (TB) in livestock, wildlife, people, and their environments with a strong global health focus. His focal research areas include improving zoonotic tuberculosis surveillance by developing state of the art diagnostic approaches and test like a) improving mycobacterial culturing, b) culture-independent qPCR detection of pathogens and c) targeted amplicon deep sequencing using numerous next generation sequencing platforms like Oxford Nanopore Technologies’ MinION mk1c device with chemistry 14 reagents. Dr Goosen has also spent many years developing wildlife species specific immunological cytokine release assays to measure host-specific delayed type hypersensitivity immunological responses towards TB antigens for the early detection of zTB infected animals to avoid possible transmission into livestock and people at park borders or in zoos. Some of the wildlife species include African buffaloes, African elephants, and black and white rhinoceros.
On a national level Dr Goosen has received the LitNet young Einstein award in 2016, the Stellenbosch University Vice Rectors Postdoctoral Fellow Award for Exceptional Achievements in 2020 and the TW Kambule NSTF award in the category emerging researcher in 2022. Internationally he received an inauguration into the National Geographic Society in 2020.
He currently holds the following degrees from Stellenbosch University; BSc in Molecular Biology as well as Biotechnology, BSc Hons in Medical Sciences, and a PhD in Molecular Biology.
Through the support of the South African Medical Research Council a large component of Dr Goosen’s research focused on improving the surveillance for zoonotic diseases with the Centre for Tuberculosis Research. Additionally, the teams most recent search focused on improving TB surveillance in water sources (including wastewater) throughout the Western Cape and Mpumalanga in and around Kruger National Park and this is done in collaboration with the SAMRC’s wastewater surveillance team.
Dr Wanga Zembe-Mkabile is a senior specialist scientist in the Health Systems Research Unit of the SAMRC. Her main interests are research and teaching in social policy, insofar as this relates to poverty and inequality, and the impact thereof on health and wellbeing. Her work seeks to contribute to understanding the impact of social determinants of health on the health system and to inform the improvement and development of best-practice methods, strategies and policies for addressing and reducing their impact on health and wellbeing. In this regard her research utilizes mixed-methods approaches that focus on social protection in the context of maternal and child health, adolescent health, communicable diseases and food security.
She has 31 lifetime publications in ISI journals, with 10 as first author. Wanga has also written 6 peer-reviewed book chapters and co-edited a book. Her lifetime research funding raised exceeds R5 million and includes a diverse range of funders both nationally (e.g. DST/NRF) and international (e.g. Global Fund).
She has been a project leader/ PI for seven projects over the past six years managing multiple projects concurrently. She is also active in capacity development. She has supervised to completion 4 masters students and am currently supervising 3 PhD’s and 1 masters student.
She has established collaborations with researchers at the University of Tampere, Finland and the Department of Social Policy and Intervention at the University of Oxford. I am also a member of an international expert network that focuses on addressing social determinants of health -the Social Protection Action Research and Knowledge Sharing (SPARKS) network. Domestically, she has collaborated on food security and maternal and child nutrition research projects as part of the University of the Western Cape’s Centre of Excellence in Food Security, and the University of Johannesburg’s Centre for Social Development in Africa (CSDA). Wanga served as a member of technical working groups focused on mothers and children and has been invited to present my research findings at multiple seminars and webinars across universities in the country. I am also a member of the Advisory Board and collaborator in the UJ-led Community of Practice for Social Systems Strengthening to Improve Child Well-being Outcomes (CoP) (2020-current) which is running a multi-year longitudinal study focusing on child outcomes such as health status, nutrition, and education.
Wanga established relationships with advocacy organisations such as The Black Sash Trust and Embrace: the Movement for Mothers. As part of my research advocacy efforts I have been invited to give expert interviews on social protection and food security topics on television, radio, and podcasts.
Prof Lebo Gafane-Matemane is an Associate Professor of Physiology under Hypertension in Africa Research Team (HART) at North-West University.
Her research focuses on cardiovascular physiology with expertise in hypertension.
Some of her achievements include being identified as one of the of the Mail & Guardian Top 200 young South Africans in 2020, winning the North-West University’s emerging teaching excellence award in 2020, a platinum award at the Stroke and Hypertension congress in 2016 and receiving the Clinical Science journal investigator award in 2018. She holds the National Research Foundation Y rating.
Professor Gafane-Matemane is currently a Fellow of the International Society of Hypertension and holds a certificate in the Fundamentals of Global Health from Utrecht University and a PhD in Physiology from North-West University.
Professor Gafane-Matemane is part of the SAMRC extramural unit of Hypertension and Cardiovascular Disease Research at North-West University.
Professor Samantha Sampson is within the Division of Molecular Biology and Human Genetics at Stellenbosch University and is a core member of the SAMRC Centre for Tuberculosis Research. She holds the DSI/NRF SARChI chair in Mycobactomics and she is also the co-director at VALIDATE vaccine development Network.
Her research on TB focuses on host-pathogen interactions. The overall goal of the Host-Pathogen Mycobactomics research group is to gain a better understanding of how the pathogen Mycobacterium TB interacts with its host to cause disease. To achieve this, they use molecular mycobacteriology and infection models together with data-rich methodologies to advance understanding of how mycobacterial features influence treatment and disease outcome.
She has twice received a research excellence award from Stellenbosch University, and has been elected to the membership of the Academy of Science of South Africa in 2021. She has received numerous national and international grants including from the NRF (SARChI and National Equipment Program) from the United States National Institutes of Health.
Professor Sampson currently holds; a Postgraduate Diploma in Leadership Development from Stellenbosch University Business School and a PhD in Medical Biochemistry from Stellenbosch University.
In addition to her TB research, she is passionate about capacity development. She has supervised over 40 postgraduate students, and is an active mentor on several formal and informal mentoring schemes aimed at advancing the development of early career researchers.
She is no stranger to the work and vision of the South African Medical Research Council, she currently serves in , the Centre for Tuberculosis research intramural unit
Dr Muki Shey is an infectious disease immunologist who serves as a Chief Research Officer at the University of Cape Town’s Department of Medicine, in the Faculty of Health Sciences.
His focal research areas are in clinical and laboratory research with expertise in immunology and infectious diseases.
Dr Shey is currently a recipient of the Welcome Trust Intermediate Fellowship in Public Health and Tropical Medicine
Dr Shey’s work has led to his service being recognized by the World Health Organisation. The WHO awarded an RFP award in 2017 for him and his team to conduct a systematic literature review on the efficacy, effectiveness, and the safety of Bacillus Calmette-Guerin (BCG) vaccines for the prevention of tuberculosis.
He received an award for innovation from the Aeras Global TB Vaccine Foundation in 2014, for his work on endpoint analyses for clinical trials of TB vaccines
He also received a travelling fellowship in immunology in 2013, jointly sponsored by the C I U Trust at the University of Oxford in the United Kingdom and SAMRC.
Dr Shey has a C2 rating from the National Research Foundation of South Africa
Dr Shey regularly reviews grant proposals for several local and international funding organisations including the Wellcome Trust, African Academy of sciences, and currently also serves as Editor for international peer-review journals including Frontiers in immunology and Scientific Reports.
Dr Shey currently holds a certificate in Project Management and a PhD in Clinical Sciences and Immunology both obtained from the University of Cape Town.
He is the current Chair of the Transformation committee of the Institute of Infectious Diseases and Molecular Medicine (IDM) and Chair of the Department of Medicine Annual Research Symposium at UCT.
Dr Shey’s work with the SAMRC deals with collaborative projects with Cochrane South Africa at SAMRC on firstly; COVID 19 influenza vaccine hesitancy among healthcare workers in Cape Town and secondly; the behavioral and social driver’s of HPV vaccination in Ethekweni district in Kwa-Zulu Natal.
He also serves on the expert review panel for TB for the SAMRC self-initiated research funding grants.
Dr Tarylee Reddy is the Director of the Biostatistics Research Unit at the South African Medical Research Council. She is the youngest unit director in the history of the SAMRC and the first female director of the biostatics research unit.
Her research focuses on statistical modeling, longitudinal data analysis, the design and analysis of clinical trials.
She has received recognition in 2021 as Top 50 women in science, technology, engineering and mathematics (STEM) by InspiringFifty. #InspiringFiftySA is an initiative in collaboration with #cocreateSANL, the national campaign of the ConsulateGeneral of the Kingdom of the Netherlands. The Dutch based non-profit
organisation aims to showcase inspiring female role models in the STEM industry in the
Netherlands, France, Europe, the Nordics, United Kingdom, Canada and South Africa.
She has authored more than 100 peer reviewed publications to date, adding critical insights to the fields of HIV, TB and COVID-19 research.
Dr Reddy currently holds; a BSc degree in Actuarial Science, a BSc Honours in Statistics (summa cum laude) , a Master’s in Statistics (cum laude) and a PhD in Statistics from the University of Hasselt in Belgium. She is an internationally recognized biostatistician who serves on several data safety monitoring boards and committees.
Dr Reddy joined the South African Medical Research Council in 2010 as a statistician within the biostatistics research unit. During her 13-year service she has advanced in the field of biostatistics through the development of novel statistical methodology.
Professor Theresa Marié Rossouw is a professor in the department of Immunology at the University of Pretoria, a member of the Gauteng Provincial Health Research Committee, the president of the South African Immunology Society, a member of the World Health Organization Research and Innovation working group on HIV-associated drug resistance, and the Associate Editor of Microbial immunology - frontiers in immunology.
Her focal research areas are in HIV infection, especially drug resistance, systemic immune activation, and immunothrombosis, as well as COVID-19, especially immunopathology and Long COVID. She also works in biomedical and research ethics, and has a special interest in autonomy and vulnerable populations.
She has been awarded the Faculty of Health Sciences Champion of Research in the category of visibility and impact and took home the first prize. In 2022 she was the finalist for the National Science and Technology Forum award, namely the TW Kambule NSTF award as a researcher with a contribution of up to 15 years of research work from the commencement of her career.
Prof Theresa Marie Rossouw has a MBChB (cum laude), MPhil in Philosophy(cum laude), an MPH in Epidemiology and Biostatistics (cum laude), a DPhil in Biomedical ethics (from Stellenbosch university) and a PhD in Medical Immunology (from the University of Pretoria).
Prof Rossouw has a long-standing relationship with several SAMRC-funded research units, principal among these being the UP Unit on Inflammation & Immunity. She is also currently affiliated with the SAMRC Research Centre for Maternal, Fetal, Newborn and Child Health Care Strategies.
Professor Sharon Prince is the Head of the Department of Human Biology, in the Faculty of Health Sciences, at the University of Cape Town.
Her research expertise lies in the fields of cancer cell and molecular biology. The primary focus of her research group has been to identify and characterise novel anti-cancer drug targets, as well as screening compounds for their potential as anti-cancer drugs in order to develop affordable therapeutic interventions for the treatment of cancers that are highly relevant to Africa. This includes breast cancer (leading cancer and most common cause of cancer-related deaths in women in Africa), cervical cancer (second most common cancer and most common cause of cancer-related deaths in women in Africa), pancreatic cancer (84% of patients diagnosed with pancreatic cancer in South Africa will die) and sarcoma (common in African children and young adults).
Professor Prince is internationally recognized as one of the pioneers and authorities in her area of research. Her work being productive in investigating the potential of (i) compounds derived from marine organisms and (ii) commercially available non-cancer drugs that can be repurposed to treat cancer.
Most recently she was elected to the UCT College of Fellows, in 2021 she received the NRF Hamilton Naki Award and in 2017 she was elected as a member of the academy of Science of South Africa.
Her qualifications include a Postgraduate diploma in higher Education, Mathematics and Physical Science, A BSc Hons in Microbiology and Chemistry and a PhD in Cell Biology all from UCT.
Prof Prince’s research over the last two decades has been in the field of health sciences and, in particular, in the identification and characterization of novel therapeutic interventions and drug targets for the treatment of cancer. During this time the SAMRC has been one of her major funders and their funding has been critical to enable her to carry out her research and train postgraduate students and postdoctoral fellows. These postgraduate students have also regularly presented and won awards at SAMRC Research Days and at the Biomedical Research & Innovation Platform (BRIP) Symposium (SAMRC).
Professor Bavesh Kana is the director of theNational Research Foundation Centre of Excellence for biomedical TB research at Wits University. He is a Research Fellow at Stellenbosch University. In addition, he is a consultant for the Bill and Melinda Gates Medical Research Institute in Cambridge, USA Professor Kana is a scientific advisor for Olilux Biosciences, a biotech company based in San Francisco, USA. He has represented South Africa on the BRICS TB Research Network.
His research focuses on TB diagnostics, vaccines and the discovery of new TB drug targets. More recently, he has directed effort towards developing new molecular diagnostics for a range of diseases. His lab is investing in developing vaccine production capacity for Africa. This investment will enable greater access to diagnostics in the developing world,
Professor Kana has received the Excellence in Academic Service award from Wits University and the CEO Titan Award for shifting the African landscape towards sustainable development in South Africa, the SADC region and the African continent. Professor Kana was featured amongst the Top 200 Mail & Guardian Young South Africans and was appointed as an Early Career Scientist of the Howard Hughes Medical Institute. He was admitted to the South African Academy of Science and was also awarded the Vice Chancellor’s Innovation Award at Wits. He has received the SAMRC Silver Medal and recently was awarded the National Science and Technology Foundation - South32 Innovation Award, or his work on innovation and knowledge translation.
Prof. Kana completed his (BSc) degree, with distinction, at Wits University in 1998, with majors in biochemistry and genetics. He subsequently completed his BSc Honours degree in biochemistry and his PhD in mycobacteriology at Wits University. He has spent time working and training at several international institutions including the Russian Academy of Sciences, Columbia University and Harvard Medical School.
The early stages of his career development were supported by the SAMRC through a career development award. Thereafter the SAMRC supported Prof Kana’s laboratory through providing scholarships for his students and focused grants on various aspects of TB and recently COVID-19. In addition, he was appointed at the SAMRC as a consultant and assisted in drafting a National Strategy for TB Research.
Prof Ameena Goga was a Chief Specialist Scientist, and Deputy Director of the Health Systems Research Unit, at the South African Medical Research Council (SAMRC), the PI of the Clinical Trials Unit of the HIV Prevention Research Unit and a Consultant in the Department of Paediatrics, at the Steve Biko Hospital, at the University of Pretoria.
Her research includes preventing vertical HIV transmission especially breastmilk HIV transmission; preventing maternal HIV acquisition and developing models / systems to improve maternal and child health at all levels of the health system, including systems to monitor long-term health outcomes.
Prof Ameena Goga is a paediatrician with master’s degrees in Mother and Child Health (ICH, London) and Epidemiology (Columbia University, USA), a PhD from the University of Pretoria and a Certificate in Paediatric Pulmonology.
Her awards include a; William Farr award in Epidemiology from Columbia University, a Patrick and Margaret Flannagen Scholarship from Rhodes university and receiving the Best Oral presentation from the South African Thoracic Society.
Prof Ameena Goga was appointed at The South African Medical Research Council (SAMRC) as the Unit Director of the HIV Prevention Research Unit (HPRU). The HPRU, Centre of Excellence in HIV prevention research on reducing HIV infections among women and men through biomedical interventions, addresses one of the leading epidemics in South Africa. Professor Goga took on the leadership of the unit with the belief that the strategic response of the HPRU is to conduct innovative and collaborative research in basic, socio-behavioural and biomedical science, in a multi-disciplinary manner, to reduce the global and national burden and impact of HIV and related diseases.
Professor Elmi Muller is a transplant surgeon who currently serves as the Dean in the Faculty of Medicine and Health Science at the University of Stellenbosch.
Her expertise and focal research areas are in: HIV, transplantation, access to healthcare and surgery. In 2008 she started the first program for HIV positive patients receiving organs from HIV positive donors in the world. This work impacted on access to healthcare for many patients who marginalized before. She has played a key role in shaping international policy documents on issues around organ trafficking and organ commercialization.
Her continued academic achievements and service has awarded her numerous accolades. In 2022 Prof Muller won the Stellenbosch University Business School alumnus of the year for Social Impact. In 2019 the UCT Alan Pifer award for research and in 2016 The Transplantation Society Women in Transplantation Hero award.
Prof Elmi Muller currently holds a;
Bachelor of Medicine and Surgery (MBChB) from the University of Pretoria
A PHD from UCT
A master’s in business administration from Stellenbosch University Business School
She is also a fellow of the college surgeons in South Africa, a member of the Royal College of Surgeons of Edinburgh and a fellow of the Amercian College of Surgeons.
She currently plays a key role in the MRC, and holds an MRC funding award for her HIV positive-to-positive transplant project. This work impacted on healthcare policy nationally and internationally.
Professor Valerie Corfield is a retiree who continues to serve in advancing research outputs and research careers of academics in molecular and cell biology, health sciences and other disciplines, performing various services at Stellenbosch University, the University of Western Cape, University of Johannesburg, the South African Medical Research Council and the National Research Foundation.
During the last three decades of her research career, she worked in the field of molecular genetics, specifically investigating the genes and mutations that cause particular inherited heart diseases found in South Africa. The research team built strong international collaborations and received considerable international funding. This work was of direct clinical translational benefit to affected individuals and families. During this time, she also supervised and mentored a large number of postgraduate students in Molecular Genetics and many have continued in research careers in South Africa and across the globe.
Professor Corfield received an NRF B-rating which is a testament to the quality of her research portfolio and profile during the last decades. Added to this, she received the Welcome Trust International Engagement award for the public communication of science, a significant “outreach” aspect of her career. Her central service to outreach is also evidenced through her receiving the national BHP Billiton/NSTF Award for Science Communication in the category of Outreach and Public Awareness.
Prof. Corfield has a BSc Honours in Botany from the University of Bristol, UK, an MSc in Cell Biology from Wright State University, USA, and a PhD in Genetics from the University of the Witwatersrand, SA.
Prof Corfield was employed by the SAMRC as a senior research scientist for 28 years that is from 1986-2014.She undertook research in the SAMRC Centre for Molecular and Cellular Biology. Part of this work included community liaising, presenting workshops and talks to schoolchildren and their teachers across South Africa.
Professor Johan Louw is a biomedical scientist who serves as the Senior Platform Director at the Centre and Platforms Office.
His expertise and focal research areas are in: Pathophysiology of metabolic disease, diabetes prevention, early diagnosis and treatment. He also has expertise in partnering and collaborating with the biotechnology industry.
He has accomplished accolades, winning an intellectual property creator award, from the then Department of Science and Technology now Department of Science and Innovation.
Professor Louw has also obtained honorary appointments, in 2016 he received the acknowledgement of being an extraordinary Professor, in the Department of Biochemistry and Microbiology from the University of Zululand.
He currently holds a, PhD in Physiology
Prof Louw has been involved in diabetes research for 35 years. In 2006 his research translated into a joint development agreement with ZADEC for innovation funding of R 120 million, this funding yielded 5 International patents.
Prof Louw started the Capacity development Programme 20 years ago.
- The Capacity developmental Programme was started because:
- There was an urgent need to develop and upskill the next generation of scientists.
- BRIP has a well-equipped laboratory infrastructure and good resources – it is these resources and structures that needed to be shared with students and researchers that work in under-resourced institutions.
- The capacity development programme trains and graduates MSc and PhD students) – at the end of 2022, it graduated 118 post- graduate students.
The programme offers a short exchange of 3, 6 or 12 months
- In 2006 BRIP secured large funding through a developmental agreement with ZADEC, ZADEC is a Danish BIOTECH Company that enabled the capacity development programme employ young technical assistants who did their MSc’s and PhD’s .
- In 2015, a strategic initiative Prof Gray initiated the RCDI Program to increase the SAMRC footprint in the under-resourced Universities otherwise referred to as HDI’s.
- Currently, eight HDI’s are participating in this initiative and BRIP’s capacity development Programme is hosting at least one student from these 8 Universities.
- During the COVID Pandemic the programme was able to set up 6 satellite COVID labs to test for the presence of COVID in wastewater
- The capacity development programme will soon start another spin-off from BRIP’s training students for the Biopharmaceutical Industry. This is where graduated students are being fully equipped for the Biopharmaceutical and Vaccine Manufacturing Industry in Africa and, specifically, South Africa.
The knowledge transfers from the Capacity Developmental Program are:
- Symposium and conferences.
- Knowledge dissemination webinars.
- Development of training modules.
- Staff skills development.
